GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H1, 2012" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myocardial Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Myocardial Ischemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Myocardial Ischemia , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Myocardial Ischemia
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Myocardial Ischemia
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Myocardial Ischemia Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Medtronic, Inc.
Clinical Trial Overview of Medtronic, Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Sanofi
Clinical Trial Overview of Sanofi
Baxter Healthcare Corporation
Clinical Trial Overview of Baxter Healthcare Corporation
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
InfraReDx, Inc.
Clinical Trial Overview of InfraReDx, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Medicure Inc.
Clinical Trial Overview of Medicure Inc.
Cytokinetics, Inc
Clinical Trial Overview of Cytokinetics, Inc
Mesoblast Limited
Clinical Trial Overview of Mesoblast Limited
Revance Therapeutics, Inc.
Clinical Trial Overview of Revance Therapeutics, Inc.
Gardia Medical Ltd.
Clinical Trial Overview of Gardia Medical Ltd.
Corindus, Inc.
Clinical Trial Overview of Corindus, Inc.
CardioVascular BioTherapeutics, Inc.
Clinical Trial Overview of CardioVascular BioTherapeutics, Inc.
Lumen Biomedical, Inc.
Clinical Trial Overview of Lumen Biomedical, Inc.
Medinol Ltd.
Clinical Trial Overview of Medinol Ltd.
Biological Signal Processing Ltd.
Clinical Trial Overview of Biological Signal Processing Ltd.
AngioScore, Inc.
Clinical Trial Overview of AngioScore, Inc.
St. Jude Medical, Inc.
Clinical Trial Overview of St. Jude Medical, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
The University of Edinburgh
Clinical Trial Overview of The University of Edinburgh
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
Hartford Hospital
Clinical Trial Overview of Hartford Hospital
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Ottawa Hospital Research Institute
Clinical Trial Overview of Ottawa Hospital Research Institute
Flinders Medical Centre
Clinical Trial Overview of Flinders Medical Centre
University Hospital Inselspital, Berne
Clinical Trial Overview of University Hospital Inselspital, Berne
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Sheba Medical Center
Clinical Trial Overview of Sheba Medical Center
VU University Medical Center
Clinical Trial Overview of VU University Medical Center
University of Schleswig-Holstein
Clinical Trial Overview of University of Schleswig-Holstein
Rambam Health Care Campus
Clinical Trial Overview of Rambam Health Care Campus
Kantonsspital Luzern
Clinical Trial Overview of Kantonsspital Luzern
Aarhus University
Clinical Trial Overview of Aarhus University
Erasmus MC
Clinical Trial Overview of Erasmus MC
Sapienza University of Rome
Clinical Trial Overview of Sapienza University of Rome
Herning Hospital
Clinical Trial Overview of Herning Hospital
Douglas W. Losordo, M.D.
Clinical Trial Overview of Douglas W. Losordo, M.D.
The Ohio State University
Clinical Trial Overview of The Ohio State University
Five Key Clinical profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Myocardial Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2012*
Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Myocardial Ischemia Global Clinical Trials Review, H1, 2012 published by GlobalData in May 21, 2012. This report consists of Pages: 145 and the price starts from US $ 1000.
The contents of this page may be different from the latest version. Please contact us for details.
